Golden China and BacTech Agree to Amend Exclusive Licensing Agreement for Proprietary BACOX(C) Technology Use

    TORONTO, June 19 /CNW Telbec/ - Golden China Resources Corporation
(GCX: TSX; ASX) today announced that it has reached an agreement to amend the
existing technology licensing agreement for the use of the proprietary
bacterial oxidation (BACOX(C)) technology employed by the company's BioGold
production facility in Shandong province, China. An amended agreement to be
entered into between subsidiaries of BacTech Mining Corporation (BM: TSX.V),
owners of the BACOX(C) technology, and Golden China will extend Golden China's
exclusive rights to the use of the BACOX(C) technology in China and Korea from
the current ten years to an open-ended term in perpetuity (subject to certain
rights of termination) and will enable Golden China to sublicense the
technology in these regions. As well, the amended agreement will remove
BacTech's entitlement to any future royalties and eliminate its right to
acquire a 5% to 15% equity interest in any future BACOX(C) operations built by
Golden China in the regions to be covered under the agreement.
    "The new licensing agreement will benefit us in several respects and
represents an important corporate development for Golden China," said
Greg Starr, President and Chief Executive Officer of Golden China. "In
addition to ensuring our rights to the BACOX(C) technology indefinitely and
allowing us to sublicense it, the amended contract will eliminate any royalty
fees that would otherwise be associated with the upcoming expansion of the
bacterial oxidation plant at our BioGold production facility. Further, it will
remove BacTech's right under the original agreement with Michelago to acquire
a 5% to 15% interest in any bacterial oxidation plants built by Golden China
in the relevant territories."
    In consideration for the amendments, Golden China will issue, subject to
required regulatory, shareholder and third party approvals, 847,458 common
shares to BacTech.
    The previous agreement entitled Golden China to exclusive use of the
BACOX(C) technology in China, Korea, Siberia and Mongolia; however, under the
terms of the new agreement, the company will agree to relinquish the rights to
the regions of Siberia and Mongolia.
    Anticipated for completion by the end of 2007, the expansion of the
company's bacterial oxidation plant at BioGold will enable Golden China to
process the significantly expanded volumes secured under its new long-term
agreement with Hellas Gold as announced in a Golden China press release of
February 7, 2007. The expansion, which will double treatment capacity from a
current 100 tonnes per day (TPD) to 200 TPD, is expected to significantly
enhance the BioGold facility's cash flow from 2008 onward.

    About Golden China Resources Corporation:

    Golden China Resources Corporation is a significant participant and
consolidator in the Chinese precious metal industry and one of the largest
producers of gold in China. The company is using its extensive knowledge of
the Chinese marketplace and best practices based on established international
standards in building a diversified gold business focused on exploration and
development, operations, and corporate development in the Chinese precious
metal industry. Golden China's shares are listed on the main boards of both
the Toronto and Australian Stock Exchanges under the symbol GCX.

    Forward-Looking Statements: Statements in this release that are
forward-looking statements are subject to various risks and uncertainties
concerning the specific factors disclosed under the heading "Risk Factors" and
elsewhere in the Company's periodic filings with Canadian securities
regulatory authorities. Such information contained herein represents
management's best judgment as of the date hereof based on information
currently available. The Company does not assume the obligation to update any
forward-looking statement.

    %SEDAR: 00009239E

For further information:

For further information: Golden China Resources Corp., Kristen Humphrey,
  Communications Manager, (416) 366-8818 ext. 230,,; Renmark Financial Communications Inc.: Barbara Komorowski,; Julien Ouimet,,
(514) 939-3989, Fax: (514) 939-3717,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890